Furazolidone and Helicobacter pylori Treatment

Amin Talebi Bezmin Abadi


We read with great interest the article published by Hosseini et al.1 in October issue of Middle East Journal of Digestive Diseases. Briefly, in this article, authors concluded that furazolidone based therapeutic regimens (in moderate and even high-dose) were not preferable for first-line treatment against H. pylori infection among the northern population in Iran.1 Altogether, some points we found may not support their final conclusion.

Full Text:


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.